Beckman Coulter News

AND BLUE OCEAN BIOMEDICAL, LLC, BOTH OF , TO BECKMAN COULTER. NPE AND BLUE OCEAN WERE TECHNOLOGY LEADERS IN THE FIELD OF FLOW CYTOMETRY WHICH PROVIDES DIAGNOSTIC BLOOD AND TISSUE TESTING FOR PATIENT MONITORING AND FOR DRUG RESEARCH.

GAITHERSBURG, Md., May 21, 2012 /PRNewswire/ -- GenVec, Inc. today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer.

After the analytical and laboratory instrumentation business saw a rebound in 2010 from the torpor of 2009, few companies expected to see the same vigor in 2011.

Beckman Coulter Inc, a leading US biomedical diagnostics instrument maker, will acquire the diagnostic systems division of Olympus' Life Sciences business for about $800 million, a joint statement issued by the companies said.